Drug development increasingly depends on networks of CROs, laboratories, technology providers, and specialized partners. Every interface can introduce risk. This presentation explores how to build high-performing multi-partner programs by selecting the right expertise, defining scientific ownership, strengthening scientist-to-scientist communication, and coordinating critical decisions. Through practical examples, attendees will learn how to prevent gaps in data transfer, responsibilities, workflows, and communication that can derail execution.
